Cebranopadol, a novel first‐in‐class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits-Reference-Cited by-同舟云学术

Cebranopadol, a novel first‐in‐class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits

Published:2021-01-25 Issue:4 Volume:44 Page:516-521
ISSN:0140-7783
Container-title:Journal of Veterinary Pharmacology and Therapeutics
language:en
Short-container-title:J Vet Pharmacol Therap

Author:

Łebkowska‐Wieruszewska Beata¹^ORCID,Gbylik‐Sikorska Małgorzata²^ORCID,Gajda Anna²^ORCID,Sartini Irene³^ORCID,Lisowski Andrzej⁴,Poapolathep Amnart⁵^ORCID,Giorgi Mario⁶⁷^ORCID

Affiliation:

1. Department of Pharmacology Toxicology and Environmental Protection University of Life Sciences Lublin Poland

2. Department of Pharmacology and Toxicology National Veterinary Research Institute Puławy Poland

3. Department of Veterinary Medicine University of Sassari Sassari Italy

4. Institute of Animal Breeding and Biodiversity Conservation University of Life Sciences Lublin Poland

5. Department of Pharmacology Faculty of Veterinary Medicine Kasetsart University Bangkok Thailand

6. Department of Veterinary Sciences University of Pisa Pisa Italy

7. PhD school Department of Veterinary Medicine University of Sassari Sassari Italy

Funder

Università di Pisa

Publisher

Wiley

Subject

General Veterinary,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvp.12948

Reference19 articles.

1. Respiratory Effects of the Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist, Cebranopadol, in Healthy Human Volunteers

2. Veterinary Pharmacology: Is it Still Pharmacology’s Cinderella?

3. Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs

4. Pharmacology of DMSO

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cebranopadol as a Novel Promising Agent for the Treatment of Pain;Molecules;2022-06-21